Director, Scientific Publications & Information

About the Department

The Clinical, Medical and Regulatory (CMR) department at Novo Nordisk is one of the most diverse and collaborative groups within the organization. From healthcare provider interactions and developing and implementing regulatory strategies with the FDA to providing medical education and collecting data to support efficacy and new product development, CMR is involved. The one thing that keeps us all marching to the same beat is our patient centered focus. At Novo Nordisk, you will help patients around the world. As their needs evolve, so does our challenge to find better and more innovative ways to improve their quality of life. We’re changing lives for a living. Are you ready to make a difference?

The Position

The Director, Scientific Publications & Information serves as the US strategic owner for integrated scientific publications, scientific information/knowledge services, and evidence dissemination excellence across therapeutic areas and lifecycle. The role leads a team of publication and information professionals; sets multi-year strategy; aligns US and global Medical Affairs, evidence generation, and launch/lifecycle priorities; and ensures compliant, timely, high-quality dissemination of company-sponsored and externally authored scientific data. Beyond content creation, the Director builds strategic information capabilities, advances responsible AI/digital solutions, manages vendors and budgets, and provides executive-ready insights that support Medical Affairs decision-making.

Relationships

Reports to the Head of Scientific Communications and directly leads the Scientific Publications & Information (SP&I) team, including potential Global Business Services/shared-service resources. Partners with USO, IO and Global Medical Affairs, Clinical Development, Clinical Data Science/Evidence, Biostatistics, HEOR/RWE, Regulatory, Legal/Compliance, AI and Machine Learning, IT, Scientific Information, Clinical Reporting/Medical Writing, and affiliate/HQ publication partners.

Leads, stands for (and delegates) SP&I on Core/Extended Medical Teams, Launch/Asset Planning teams, Publication Planning Groups (or IEP), Core Publications Working Groups, Global Project Teams(as needed/delegated by AVP), evidence planning forums, and governance bodies. Externally, manages compliant relationships with authors, investigators, external experts/KOLs, journal editors/publishers, congress organizers, medical writing agencies, publication/information vendors, and professional organizations/industry consortia.

Essential Functions

• General / Strategic Leadership and Governance
  • Operates independently as the US functional leader for SP&I strategy, governance, operational excellence, and capability building across therapeutic areas
  • Owns and refreshes integrated US publication, scientific information, and evidence dissemination strategy by therapy area/asset; ensures alignment with global plans, US medical strategy, launch/lifecycle priorities, data milestones, and stakeholder needs
  • Chairs or oversees publication planning groups, governance forums, and annual planning workshops; drives prioritization, risk management, decision documentation, and escalation of strategic or compliance issues
  • Translates medical strategy, evidence gaps, landscape/competitive intelligence, stakeholder insights, and data milestones into prioritized publication and information plans
  • Defines and reports KPIs/dashboards for plan progress, submission/publication timelines, scientific quality, journal/congress strategy, reach/engagement, author experience, compliance, budget/vendor performance, and operational efficiency
  • Develops, updates, and trains stakeholders on SOPs/work practices for GPP 2022, ICMJE authorship/contributorship, disclosures, data transparency, copyright, publication systems, AI use, and audit readiness
  • Provides executive-ready insights and recommendations to Medical Affairs leadership, Core/Extended Medical Teams, launch teams, and global partners
  • Manages SP&I base/launch budgets, forecasting, phasing, vendor sourcing, performance management, resource allocation, and continuous improvement
• Publications / Scientific Communications
  • Accountable for strategy, quality, scientific rigor, and governance of manuscripts, abstracts, posters, oral presentations, plain-language summaries, publication extenders, scientific platforms, and related evidence dissemination ass